Polygenic testing startups offer consumers the chance of a “superbaby” by screening for genetic disorders and allowing parents to select certain embryos for fertilization; however, the ethics and the science of this practice are very controversial. Speaking to The San Francisco Standard, Professor Jacob Sherkow added his expertise on the issue. “[These companies] claim to have a proprietary algorithm, which, in reality, is a total black box,” he said. “If they are not completely accurate, consumers may make adverse health choices on the basis of misinformation.”
